Vet-AI

What they do

Vet-AI makes software for the veterinary sector, focused on the gap between pet owners and quality care. The company's core argument is straightforward: vet costs are rising, pet ownership is growing, and vets are burning out. Their products are designed to engage owners earlier in the care journey, reducing pressure on clinics while improving outcomes for animals.

The technology is clinically validated — a phrase the company uses deliberately, and backs up with a stated process of real-world testing involving pet owners, veterinary experts and industry bodies. Accuracy matters here in a way it doesn't in most software: a wrong triage recommendation can affect a patient's health. Vet-AI says they test extensively before release and treat even small inaccuracies as a serious concern.

The company was co-founded by two practising UK vets, which shapes how the product is built. Vets and developers work alongside each other rather than in sequence. The clinical team isn't a sign-off function; they're embedded in the development process. That structure is relatively unusual in healthtech, where clinical input often arrives late.

Vet-AI operates on a partnership model. Rather than selling direct to consumers at scale, they work with other organisations in the veterinary and pet industry to distribute their technology. The contact and demo flow on their site is aimed at businesses, not individual pet owners.

The team is remote-first, with a co-working space allowance available. They hold regular company-wide gatherings — a summer and Christmas all-hands — and describe a culture built around flexibility and collaboration. They're actively hiring across engineering, design, data science and veterinary roles.

What sets them apart

Most veterinary software is built for practices: appointment booking, clinical records, billing. Vet-AI's focus is the owner side of the relationship — the moment before someone decides whether to call the vet, book an appointment or wait and see. That's a less crowded space, and it's where the company has chosen to build.

The co-founder background matters. Being founded by practising vets rather than technologists gives the company credibility with veterinary professionals and with the industry bodies whose endorsement matters for clinical software. It also means the product decisions are grounded in how veterinary care actually works, not how an outsider imagines it works.

Their stated obsession with validation is worth taking seriously. In a sector where a wrong answer has welfare consequences, the bar for accuracy is higher than in most consumer apps. Vet-AI's safety standards page and repeated references to real-world testing suggest this is a genuine operational priority rather than a marketing claim.

Founded in 2019, they've had time to iterate and build partnerships. The company describes itself as growing quickly and is actively expanding the team. They have Trustpilot reviews referenced on their contact page, suggesting a live user base rather than a product still in development.

The partnership-first distribution model means their technology can reach more pets than a direct-to-consumer approach would allow. It also means their commercial relationships are with veterinary businesses and insurers rather than individual owners — a B2B2C structure that's common in healthtech and tends to produce more durable revenue.

What they offer

• AI triage and symptom checking — clinically validated tools that help pet owners assess whether their animal needs veterinary attention, tested with vets and industry bodies before release.
• Telehealth platform — connects pet owners with veterinary professionals remotely, reducing barriers created by cost and access.
• Partner-facing technology — distributed via partnerships with veterinary and pet industry organisations rather than sold direct to consumers.